Dissolvable microneedle eye patch development & private label manufacturingWhatsApp：+852 6240 8962Email：info@hytanbio.com
MicroneedleEye Patch
Microneedle Eye Patch

Acetyl Hexapeptide-8 Microneedle Eye Patch

Private-label acetyl hexapeptide-8 and Argireline microneedle eye patch development for cosmetic fine-line and smoothing programs.

OEM answer

Private-label acetyl hexapeptide-8 and Argireline microneedle eye patch development for cosmetic fine-line and smoothing programs. The finished specification is developed around intended market, formula compatibility, crescent geometry, array integrity, backing, barrier packaging and responsible eye-area directions.

Unbranded custom dissolvable microneedle eye patch OEM samples

Recommended product brief

Positioning

Expression-line appearance and smoothing positioning

Formula direction

Acetyl hexapeptide-8 cosmetic concept with a compatible polymer matrix, humectants and project-appropriate supporting ingredients

Cosmetic claim territory

Temporary smoothing and improvement in the appearance of under-eye fine lines without botulinum toxin comparisons or medical claims

Custom options

Patch contour, array area, backing, wear instructions, pouch, carton, pair count and private-label artwork.

What must be confirmed during development

  1. Category and use area: confirm cosmetic classification, eye-area suitability, intended frequency and destination-market constraints.
  2. Matrix and active compatibility: evaluate pH, water activity, mixing, time, temperature, oxidation and distribution within the micro-array.
  3. Geometry and handling: align needle height, base width, density, array footprint, crescent contour, backing stiffness and application pressure.
  4. Finished-pack evidence: plan integrity, dimensional, microbiological, stability, packaging and appropriate safety or claim substantiation for the actual product.

Customization and commercial planning

A standard platform can reduce development time. A custom formula, exclusive geometry, new tooling or complex retail pack may improve differentiation but also changes feasibility work, testing, MOQ, cost and lead time. We provide project-specific assumptions after reviewing a non-confidential brief.

Responsible-use boundary. This page describes cosmetic product-development concepts, not medical advice or guaranteed effects. Ingredient eligibility, safety, claims, instructions and commercialization requirements must be confirmed for the complete finished product in each target market.

Related eye patch platforms

Request formula and sample options

HYTANBIO · CHANGZHOU BASE

A source-based peptide eye-patch configuration.

The HYTANBIO portfolio lists a 750-needle HA eye-patch configuration with Acetyl Hexapeptide-8, Hexapeptide-9 and Tripeptide-1 as its peptide formulation reference. The nominal height envelope is 300–1,000 µm; size and color can be reviewed for the brief. This is a separate catalogue configuration, not a validated formula or a specification for every peptide platform.

View the peptide array and packaging references →

Source: HYTANBIO Microneedle Product Portfolio, Changzhou Base, 22 pages. Integrated and reviewed 15 October 2026. Catalogue values are configuration references, not finished-product clinical evidence or market authorization.

Download the complete source portfolio · Discuss a configuration brief
Scroll to Top